Showing results (621-630 of 703) with videos related to

Sort By:
Pageof 71
Blood Advances|September 16, 2021
Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?Brandon S Imber, Karen W Chau, Jasme Lee, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 12, 2020
Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilitiesAmir Ben-Shmuel, Tal Brosh-Nissimov, Itai Glinert, et al.
Blood|February 7, 2001
A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic modelC H Moskowitz, S D Nimer, A D Zelenetz, et al.
Blood|February 3, 1998
T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host diseaseE B Papadopoulos, M H Carabasi, H Castro-Malaspina, et al.
Cell Reports|November 2, 2024
Candidate stem cell isolation and transplantation in HexacoralliaShani Talice, Itamar Kozlovski, Shany K Barkan, et al.
Haematologica|August 30, 2023
Diffuse large B-cell lymphoma involving osseous sites: utility of response assessment by PET/CT and good longterm outcomesPaola Ghione, Salma Ahsanuddin, Efrat Luttwak, et al.
Gastroenterology|March 9, 2026
Perturbations of Diet and Gut Signatures Persist During Remission in Crohn's Disease Despite Effective Immune SuppressionTzipi Braun, Nina Levhar, Gilat Efroni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphomaC H Moskowitz, J R Bertino, J R Glassman, et al.
Nature Communications|August 29, 2020
A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopesTal Noy-Porat, Efi Makdasi, Ron Alcalay, et al.
Vaccines|February 26, 2022
Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human SeraYfat Yahalom-Ronen, Noam Erez, Morly Fisher, et al.
Pageof 71